Journal of Critical Care
Volume 24, Issue 1 , Pages 29-35 , March 2009

Preclinical pharmacology of sugammadex

  • Anton Bom, MD, PhD

      Affiliations

    • Department of Pharmacology, Schering-Plough Corporation, Newhouse, ML1 5SH Scotland, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 1698 736454.
    • ,
  • Frank Hope, BSc

      Affiliations

    • Department of Pharmacology, Schering-Plough Corporation, Newhouse, ML1 5SH Scotland, United Kingdom
    • ,
  • Samantha Rutherford, PhD

      Affiliations

    • Department of Analytical Chemistry, Schering-Plough Corporation, Newhouse, ML1 5SH Scotland, United Kingdom
    • ,
  • Karen Thomson, BSc

      Affiliations

    • Department of Pharmacology, Schering-Plough Corporation, Newhouse, ML1 5SH Scotland, United Kingdom

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0883-9441(08)00233-5

doi: 10.1016/j.jcrc.2008.10.010

Journal of Critical Care
Volume 24, Issue 1 , Pages 29-35 , March 2009

Article Tools

* Image Usage & Resolution